Prime Capital Investment Advisors’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $415K | Buy |
10,811
+924
| +9% | +$35.5K | 0.01% | 666 |
|
|
2025
Q1 | $383K | Buy |
9,887
+569
| +6% | +$22K | ﹤0.01% | 750 |
|
|
2024
Q4 | $315K | Sell |
9,318
-35
| -0.4% | -$1.18K | ﹤0.01% | 714 |
|
|
2024
Q3 | $382K | Sell |
9,353
-74
| -0.8% | -$3.03K | 0.01% | 660 |
|
|
2024
Q2 | $363K | Sell |
9,427
-1,470
| -13% | -$56.6K | 0.01% | 666 |
|
|
2024
Q1 | $467K | Sell |
10,897
-528
| -5% | -$22.6K | 0.01% | 637 |
|
|
2023
Q4 | $423K | Sell |
11,425
-1,408
| -11% | -$52.2K | 0.01% | 618 |
|
|
2023
Q3 | $465K | Sell |
12,833
-789
| -6% | -$28.6K | 0.01% | 479 |
|
|
2023
Q2 | $485K | Buy |
13,622
+269
| +2% | +$9.59K | 0.01% | 489 |
|
|
2023
Q1 | $475K | Buy |
13,353
+2,916
| +28% | +$104K | 0.02% | 353 |
|
|
2022
Q4 | $367K | Buy |
10,437
+3,592
| +52% | +$126K | 0.01% | 383 |
|
|
2022
Q3 | $201K | Buy |
+6,845
| New | +$201K | 0.01% | 383 |
|
|
2020
Q4 | – | Sell |
-109
| Closed | -$5K | – | 471 |
|
|
2020
Q3 | $5K | Sell |
109
-473
| -81% | -$21.7K | ﹤0.01% | 418 |
|
|
2020
Q2 | $30K | Buy |
582
+4
| +0.7% | +$206 | ﹤0.01% | 360 |
|
|
2020
Q1 | $27K | Sell |
578
-2
| -0.3% | -$93 | ﹤0.01% | 329 |
|
|
2019
Q4 | $34K | Buy |
580
+100
| +21% | +$5.86K | ﹤0.01% | 346 |
|
|
2019
Q3 | $26K | Buy |
+480
| New | +$26K | ﹤0.01% | 384 |
|
|
2019
Q1 | – | Sell |
-11
| Closed | -$1K | – | 362 |
|
|
2018
Q4 | $1K | Buy |
+11
| New | +$1K | ﹤0.01% | 343 |
|
|
2018
Q1 | – | Sell |
-768
| Closed | -$34K | – | 257 |
|
|
2017
Q4 | $34K | Buy |
+768
| New | +$34K | 0.03% | 177 |
|